SCHEMBL19905

SCHEMBL19905

Bc1c(C2CCC(N)(C(=O)O)CC2)nc2c(-c3ccc(-c4ccccc4)nc3)cnn2c1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.45
RPTOR Q8N122 5/20 0.45
MLST8 Q9BVC4 5/20 0.45
CHEK1 O14757 4/20 0.37
CCNA2 P20248 4/20 0.37
CDK2 P24941 4/20 0.37
CCNA1 P78396 4/20 0.37
NPC1 O15118 6/20 0.36
RAB9A P51151 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
JAK1 P23458 1/20 0.36
CASP3 P42574 2/20 0.36
SENP8 Q96LD8 2/20 0.36
SENP7 Q9BQF6 2/20 0.36
SENP6 Q9GZR1 2/20 0.36
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22077 0.90 MTOR (0.44) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL15007415 0.90 CHEK1 (0.47) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL7882443 0.89 MTOR (0.43) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL7874518 0.88 MTOR (0.42) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL20164 0.87 MTOR (0.43) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL7882475 0.86 CHEK1 (0.46) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL7885824 0.85 MTOR (0.44) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL20333 0.85 MTOR (0.41) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL7878823 0.85 MTOR (0.45) MTORRPTORMLST8CHEK1CCNA2
SCHEMBL20761 0.84 CHEK1 (0.52) MTORRPTORMLST8CHEK1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed